{
    "Trade/Device Name(s)": [
        "Neonatal Bilirubin (nBili) on Rapidlab 1200 Blood Gas Systems",
        "Neonatal Bilirubin (nBili) on Rapidlab models 1245 and 1265"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics",
    "510(k) Number": "K073537",
    "Predicate Device Reference 510(k) Number(s)": [
        "K043218",
        "K991417"
    ],
    "Regulatory Class": "Class I reserved",
    "Product Code(s)": [
        "MQM"
    ],
    "Summary Letter Date": "June 23, 2008",
    "Summary Letter Received Date": "June 24, 2008",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1113"
    ],
    "Regulation Name(s)": [
        "Bilirubin (total and unbound) in the neonate test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Total neonatal bilirubin"
    ],
    "Specimen Type(s)": [
        "Whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Rapidlab 1245 analyzer",
        "Rapidlab 1265 analyzer",
        "Rapidlab 1200 blood gas systems"
    ],
    "Method(s)/Technology(ies)": [
        "Multiple wavelength spectrophotometry",
        "CO-oximetry"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Test"
    ],
    "Document Summary": "FDA 510(k) summary for Neonatal Bilirubin (nBili) test on Rapidlab 1245/1265 analyzers for determining neonatal bilirubin in whole blood using spectrophotometry.",
    "Indications for Use Summary": "In vitro diagnostic test on Rapidlab 1245 and 1265 analyzers for determining total neonatal bilirubin concentration in whole blood of newborn infants; aids in assessing the risk of kernicterus.",
    "fda_folder": "Clinical Chemistry"
}